When DNA Repair Backfires – Trabectedin Induces DNA Breaks in Active Genes

Authors

  • Vakil Takhaveev Department of Health Sciences and Technology, ETH Zürich, CH-8092 Zürich, Switzerland
  • Kook Son Center for Genomic Integrity, Institute for Basic Science, 44919 Ulsan, Republic of Korea
  • Visesato Mor Center for Genomic Integrity, Institute for Basic Science, 44919 Ulsan, Republic of Korea
  • Hobin Yu Center for Genomic Integrity, Institute for Basic Science, 44919 Ulsan, Republic of Korea; Department of Biological Sciences, Ulsan National Institute of Science and Technology, 4919 Ulsan, Republic of Korea
  • Emma Dillier Department of Health Sciences and Technology, ETH Zürich, CH-8092 Zürich, Switzerland
  • Nicola Zilo Institute of Molecular Biology, 55128, Mainz, Germany
  • Nikolai J. L. Püllen Department of Health Sciences and Technology, ETH Zürich, CH-8092 Zürich, Switzerland
  • Dmitri Ivanov Center for Genomic Integrity, Institute for Basic Science, 44919 Ulsan, Republic of Korea
  • Helle D. Ulrich Institute of Molecular Biology, 55128, Mainz, Germany
  • Shana J. Sturia Department of Health Sciences and Technology, ETH Zürich, CH-8092 Zürich, Switzerland
  • Orlando D. Schärer Center for Genomic Integrity, Institute for Basic Science, 44919 Ulsan, Republic of Korea; Department of Biological Sciences, Ulsan National Institute of Science and Technology, 4919 Ulsan, Republic of Korea

DOI:

https://doi.org/10.2533/chimia.2025.237

PMID:

40314298

Keywords:

DNA repair, Genomics, Precision oncology, Trabectedin

Abstract

Many anticancer drugs are ineffective in tumors that have functional DNA repair mechanisms. In contrast, trabectedin, a tetrahydroisoquinoline alkaloid marine natural product, stands out as it is more lethal to cancer cells with active DNA repair, particularly transcription-coupled nucleotide excision repair (TC-NER), making it an intriguing alternative to standard chemotherapeutic agents. To optimize trabectedin’s use in precision oncology, it is essential to understand how its toxicity depends on TC-NER. In this study, we reveal that incomplete TC-NER of trabectedin-DNA adducts generates persistent single-strand breaks (SSBs). These adducts are found to obstruct the second of two sequential NER-mediated DNA incisions. By mapping the 3'-hydroxyl groups of SSBs resulting from the first NER incision at trabectedin-DNA adducts, we achieve genome-wide visualization of TC-NER. Our findings show that trabectedin-induced SSBs predominantly occur in the transcribed strands of active genes, accumulating near transcription start sites. This work provides new insights into how trabectedin can be leveraged for targeted cancer therapies and for studying TC-NER and transcription.

Funding data

Downloads

Published

2025-04-30

How to Cite

[1]
V. Takhaveev, K. Son, V. Mor, H. Yu, E. Dillier, N. Zilo, N. J. L. Püllen, D. Ivanov, H. D. Ulrich, S. J. Sturia, O. D. Schärer, Chimia 2025, 79, 237, DOI: 10.2533/chimia.2025.237.